Trigonelline, a coffee‐derived alkaloid with antioxidant and mitochondrial effects, has been proposed as a candidate modulator of aging, but its specific role in ovarian aging remains unclear. In this study, we applied an integrated in silico strategy combining network pharmacology, protein–protein interaction analyses, molecular docking, 100‐ns molecular dynamics simulations, and single‐cell transcriptomic data to identify potential trigonelline targets relevant to ovarian aging. Among 57 predicted targets, five (MMP9, JAK2, PARP1, HDAC1, and CYP3A4) emerged as core candidates spanning extracellular matrix remodeling, genome and epigenome maintenance, and endocrine/xenobiotic metabolism. Structural and molecular dynamics simulations combined with single‐cell expression patterns converged on PARP1 and MMP9 as the most plausible central mediators of trigonelline's putative age‐modulating effects in the ovary, with JAK2 and HDAC1 as intermediate candidates and CYP3A4 as a likely systemic mediator. These exploratory findings provide a conceptual framework that links coffee‐derived trigonelline to molecular pathways of ovarian aging and highlight specific targets and pathways for experimental validation in future nutrition and reproductive‐aging studies.
Mitochondrial dysfunction plays a critical role in ovarian aging and the associated decline in female fertility. Nicotinamide riboside (NR), a vitamin B3 derivative and dietary NAD + precursor, has shown antiaging potential, yet its molecular mechanisms in ovarian function are not fully understood. In this study, we investigated the effects of NR on oocyte maturation, mitochondrial membrane potential, and mitochondrial distribution in aged mice. Using network pharmacology and protein–protein interaction analyses, we identified 54 potential NR‐related targets involved in ovarian aging, with CASP3, PTGS2, PARP1, REN, and ACE highlighted as central hub genes. Molecular docking and 100‐nanosecond molecular dynamics simulations confirmed stable and energetically favorable binding between NR and these targets, particularly PTGS2 and ACE, suggesting strong regulatory potential. To further place these targets in a physiological context, we reanalyzed publicly available human ovarian single‐cell RNA sequencing data and observed age‐associated remodeling of ACE, REN, PTGS2, and PARP1 expression across granulosa, theca/stromal, and endothelial cell populations, supporting their relevance within the ovarian microenvironment. NR treatment significantly enhanced the maturation rate and mitochondrial function of aged oocytes, indicating its ability to restore mitochondrial health and modulate key aging‐related pathways. These findings provide mechanistic insights into NR’s protective role in reproductive aging and support its potential as a nutritional intervention to promote female reproductive longevity.
13 October 2026 in Journal of Assisted Reproduction and Genetics